http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110141599-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc5c91f700724201dbc9047eb097b00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2018-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60fdc6247f53553de893b872c75bb0d
publicationDate 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110141599-A
titleOfInvention A special ointment for chronic catarrhal conjunctivitis and preparation method thereof
abstract The invention provides a special ointment for chronic catarrhal conjunctivitis, which is composed of 8 g of broken ganoderma lucidum spore powder, 3 g of roselle, 5 g of honeysuckle, 2 g of borneol and 3 g of Sophora japonica, wherein the broken ganoderma spore powder has a polysaccharide content of 0.2- 3%, the triterpene content is 2.5-3%, the ash content≤6%, and the sulfur content is lower than 5ppm; the present invention also provides a preparation method, including ultrasonic irradiation, powder making, homogenization and paste making, the ultrasonic Irradiation, the ultrasonic frequency is 18kHz, the ultrasonic power is 300W, and the ultrasonic time is 250min; a kind of special ointment for chronic catarrhal conjunctivitis of the present invention has synergistic effect between each component, and the effect is greater than the sum of the effects of the individual components, reaching The purpose of synergistically eliminating cold evil, while treating both symptoms and root causes, is not easy to relapse, does not produce drug resistance, the total effective rate is high, the total effective rate can reach 96%, the course of treatment is short, 7-10 days can be cured, no toxin, to achieve rapid cure Effect.
priorityDate 2018-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID183260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165166
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452858641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6552009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID183260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426088935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556761

Total number of triples: 36.